Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia.
Blood Cancer J. 2022 Jan 28;12(1):20. doi: 10.1038/s41408-022-00621-9.
Blood Cancer J. 2022.
PMID: 35091541
Free PMC article.
No abstract available.